ニキビ治療薬市場レポート：2030年までの動向、予測、競合分析

ニキビ治療薬の動向と予測

世界のニキビ治療薬市場は、2024年から2030年にかけてCAGR 4.2%で成長すると予測されます。この市場の主な促進要因は、ライフスタイルの変化と皮膚疾患の増加です。世界のニキビ治療薬市場は、局所薬、経口薬、注射薬の各市場における機会により、将来が有望視されています。

セグメント別のニキビ治療薬

本調査では、世界のニキビ治療薬のタイプ別、治療クラス別、投与方法別、地域別の予測を掲載しています。

ニキビ治療薬市場の洞察

Lucintel社は、細菌感染症例の増加により、炎症性疾患が予測期間中最大のセグメントであり続けると予測しています。

この市場において、局所薬は引き続き最大セグメントです。

北米は、ライフスタイルの変化と疾患罹患率の増加により、予測期間中も最大の地域であり続けるでしょう。

よくある質問

Q1.市場の成長予測は：

A1.世界のニキビ治療薬市場は、2024年から2030年にかけてCAGR 4.2%で成長すると予想されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、ライフスタイルの変化と皮膚疾患の増加です。

Q3.市場の主要セグメントは：

A3.にきび治療薬市場の将来は、局所薬、経口薬、注射薬市場に機会があり、有望です。

Q4.市場の主要企業は：

A4.主要なニキビ治療薬企業は以下の通り：

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、細菌感染症例の増加により、予測期間中、炎症性疾患が最大セグメントであり続けると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.ライフスタイルの変化と疾患罹患率の増加により、予測期間中も北米が最大地域です。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のニキビ治療薬市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のニキビ治療薬市場の動向（2018～2023年）と予測（2024～2030年）
• タイプ別の世界のニキビ治療薬市場
  • 面皰性
  • 炎症性
  • 嚢胞性
  • 術後/創傷
• 治療クラス別の世界のニキビ治療薬市場
  • レチノイド
  • 抗生物質
  • ホルモン剤
  • 配合
  • その他
• 投与方法別の世界のニキビ治療薬市場
  • 局所
  • 経口
  • 注射

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のニキビ治療薬市場
• 北米のニキビ治療薬市場
• 欧州のニキビ治療薬市場
• アジア太平洋地域のニキビ治療薬市場
• その他地域のニキビ治療薬市場

第5章 競合分析

• 製品ポートフォリオ分析
• 業務統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
• 世界のニキビ治療薬市場の新たな動向
• 戦略分析
  • 新製品の開発
  • 世界のニキビ治療薬市場の生産能力拡大
  • 世界のニキビ治療薬市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Acne Drug Trends and Forecast

The future of the global acne drug market looks promising with opportunities in the topical, oral, and injectable markets. The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are changing lifestyle and increasing dermatological diseases.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Acne Drug by Segment

The study includes a forecast for the global acne drug by type, therapeutic class, mode of administration, and region.

Acne Drug Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Comedonal
• Inflammatory
• Cystic
• Postsurgical/Wound

Acne Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

• Retinoid
• Antibiotic
• Hormonal Agent
• Combination
• Others

Acne Drug Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Topical
• Oral
• Injectable

Acne Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acne Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acne drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acne drug companies profiled in this report include-

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Acne Drug Market Insights

Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Within this market, topical will remain the largest segment.

North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Features of the Global Acne Drug Market

Market Size Estimates: Acne drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acne drug market size by type, therapeutic class, mode of administration, and region in terms of value ($B).

Regional Analysis: Acne drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, therapeutic classes, mode of administration, and regions for the acne drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acne drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for acne drug market?

Answer: The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the acne drug market?

Answer: The major drivers for this market are changing lifestyle and increasing dermatological diseases.

Q3. What are the major segments for acne drug market?

Answer: The future of the acne drug market looks promising with opportunities in the topical, oral, and injectable markets.

Q4. Who are the key acne drug market companies?

Answer: Some of the key acne drug companies are as follows:

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5. Which acne drug market segment will be the largest in future?

Answer: Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Q6. In acne drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acne drug market by type (comedonal, inflammatory, cystic, and postsurgical/wound), therapeutic class (retinoid, antibiotic, hormonal agent, combination, and others), mode of administration (topical, oral, and injectable), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acne Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acne Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acne Drug Market by Type
  • 3.3.1: Comedonal
  • 3.3.2: Inflammatory
  • 3.3.3: Cystic
  • 3.3.4: Postsurgical/Wound
• 3.4: Global Acne Drug Market by Therapeutic Class
  • 3.4.1: Retinoid
  • 3.4.2: Antibiotic
  • 3.4.3: Hormonal Agent
  • 3.4.4: Combination
  • 3.4.5: Others
• 3.5: Global Acne Drug Market by Mode of Administration
  • 3.5.1: Topical
  • 3.5.2: Oral
  • 3.5.3: Injectable

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acne Drug Market by Region
• 4.2: North American Acne Drug Market
  • 4.2.1: North American Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.2.2: North American Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.3: European Acne Drug Market
  • 4.3.1: European Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.3.2: European Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.4: APAC Acne Drug Market
  • 4.4.1: APAC Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.4.2: APAC Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.5: ROW Acne Drug Market
  • 4.5.1: ROW Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.5.2: ROW Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acne Drug Market by Type
  • 6.1.2: Growth Opportunities for the Global Acne Drug Market by Therapeutic Class
  • 6.1.3: Growth Opportunities for the Global Acne Drug Market by Mode of Administration
  • 6.1.4: Growth Opportunities for the Global Acne Drug Market by Region
• 6.2: Emerging Trends in the Global Acne Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acne Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acne Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
• 7.2: Bayer
• 7.3: Galderma
• 7.4: Stiefel
• 7.5: Valeant